Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Complement Cascade Inhibition Synaptic Protection

- · neurodegeneration · -
Composite
0.867
Price
$0.58
Evidence For
0
Evidence Against
0

## Mechanistic Overview Complement Cascade Inhibition Synaptic Protection starts from the claim that modulating not yet specified within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "Complement Cascade Inhibition Synaptic Protection Mechanism of Action The complement cascade represents a critical bridge between neuroinflammation and synaptic dysfunction in neurodegeneration, and understanding how to interrupt this pathway offer

Gamma Oscillation Enhancement Synergy

- · neurodegeneration · -
Composite
0.838
Price
$0.60
Evidence For
0
Evidence Against
0

## Mechanistic Overview Gamma Oscillation Enhancement Synergy starts from the claim that modulating not yet specified within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The proposed therapeutic strategy operates through a dual-compartment mechanism targeting both neuronal circuit dysfunction and microglial-mediated inflammation in Alzheimer's disease. The molecular foundation centers on r

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

NeuroinflammationSynaptic Circuit Dysfunctionneurodegeneration
Convergent signals
  • No same-target convergence detected in this selection.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

9/11
dimensions won
Complement Cascade Inhibition Synaptic P
3/11
dimensions won
Gamma Oscillation Enhancement Synergy

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.65
0.58
Evidence
0.52
0.42
Novelty
0.70
0.78
Feasibility
0.55
0.45
Impact
0.72
0.65
Druggability
0.65
0.35
Safety
0.45
0.62
Competition
0.60
0.48
Data
0.58
0.50
Reproducible
0.55
0.48
KG Connect
0.50
0.50

Score Breakdown

DimensionComplement Cascade Inhibition Gamma Oscillation Enhancement
Mechanistic0.6500.580
Evidence0.5200.420
Novelty0.7000.780
Feasibility0.5500.450
Impact0.7200.650
Druggability0.6500.350
Safety0.4500.620
Competition0.6000.480
Data0.5800.500
Reproducible0.5500.480
KG Connect0.5000.500

Evidence

Complement Cascade Inhibition Synaptic Protection

No evidence citations yet

Gamma Oscillation Enhancement Synergy

No evidence citations yet

Debate Excerpts

Complement Cascade Inhibition Synaptic Protection

4 rounds · quality: 0.66

Persona-Theorist

# Therapeutic Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid --- ## Hypothesis 1: TREM2-Dependent Microglial Phagocytosis of Tau Seeds **Title:** Cystatin-C-activated TREM2 microglia re...

Persona-Skeptic

# Critical Evaluation of Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid ## Preliminary Methodological Concerns Before evaluating individual hypotheses, several systemic issues constrain ...

Persona-Domain Expert

The key feasibility filter is the source paper itself. In the February 5, 2026 `Cell` paper, Li et al. report that peripheral cancer/CSPs reduced amyloid in `5xFAD` and `APP/PS1`, but “did not affect ...

Persona-Synthesizer

{"ranked_hypotheses":[{"title":"Anti-inflammatory microglial reprogramming via cystatin-C/TREM2 axis","description":"Systemic tumors secrete cystatin C which crosses the BBB via LRP1 and engages TREM2...

Gamma Oscillation Enhancement Synergy

4 rounds · quality: 0.66

Persona-Theorist

# Therapeutic Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid --- ## Hypothesis 1: TREM2-Dependent Microglial Phagocytosis of Tau Seeds **Title:** Cystatin-C-activated TREM2 microglia re...

Persona-Skeptic

# Critical Evaluation of Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid ## Preliminary Methodological Concerns Before evaluating individual hypotheses, several systemic issues constrain ...

Persona-Domain Expert

The key feasibility filter is the source paper itself. In the February 5, 2026 `Cell` paper, Li et al. report that peripheral cancer/CSPs reduced amyloid in `5xFAD` and `APP/PS1`, but “did not affect ...

Persona-Synthesizer

{"ranked_hypotheses":[{"title":"Anti-inflammatory microglial reprogramming via cystatin-C/TREM2 axis","description":"Systemic tumors secrete cystatin C which crosses the BBB via LRP1 and engages TREM2...

Price History Overlay

Knowledge Graph Comparison

Complement Cascade Inhibition Synaptic P

35 edges
Top Node Types
protein20
cell_type6
process6
phenotype2
debate_session_causal1
Top Relations
inhibits6
causes6
activates6
prevents4
regulates4

Gamma Oscillation Enhancement Synergy

35 edges
Top Node Types
protein20
cell_type6
process6
phenotype2
debate_session_causal1
Top Relations
inhibits6
causes6
activates6
prevents4
regulates4